Cardiff Oncology, Inc. (CRDF) Ownership

$2.16

$0.03 (1.41%)
Last update: 04:00 PM EST
Day's range
$2.1
Day's range
$2.2

Cardiff Oncology, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 11/12/2025 3.99 M $8.21 M   1.25% 5.99%
VANGUARD GROUP INC 11/07/2025 3.59 M $7.39 M   -3.74% 5.39%
LAURION CAPITAL MANAGEMENT LP 11/17/2025 2.47 M $5.08 M   37.20% 3.71%
PFIZER INC 11/13/2025 2.41 M $4.97 M   0.00% 3.63%
BLAIR WILLIAM & CO/IL 11/12/2025 2.21 M $4.56 M   -12.30% 3.33%
ACORN CAPITAL ADVISORS, LLC 11/17/2025 1.96 M $4.04 M   39.28% 2.95%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 1.54 M $3.18 M   2.97% 2.32%
STATE STREET CORP 11/14/2025 1.15 M $2.36 M   1.76% 1.72%
UBS GROUP AG 11/13/2025 633.00 K $1.30 M   0.00% 0.95%
FLPUTNAM INVESTMENT MANAGEMENT CO 10/10/2025 597.23 K $1.23 M   1,008.80% 0.90%
NORTHERN TRUST CORP 11/14/2025 519.75 K $1.07 M   -28.26% 0.78%
GOLDMAN SACHS GROUP INC 11/14/2025 454.73 K $936.74 K   495.71% 0.68%
BANK OF NEW YORK MELLON CORP 11/03/2025 347.49 K $715.82 K   4.05% 0.52%
MORGAN STANLEY 11/14/2025 310.66 K $639.96 K   -60.96% 0.47%
CITADEL ADVISORS LLC 11/14/2025 227.90 K $469.47 K   166.24% 0.34%
NATIONAL BANK OF CANADA /FI/ 11/14/2025 208.70 K $429.92 K   652,087.50% 0.31%
UBS GROUP AG 11/13/2025 206.18 K $424.72 K   4.43% 0.31%
TWO SIGMA INVESTMENTS, LP 11/14/2025 204.01 K $420.26 K   -54.00% 0.31%
NUVEEN, LLC 11/12/2025 194.31 K $400.28 K   -65.32% 0.29%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 189.32 K $389.99 K   0.00% 0.28%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 184.10 K $379.25 K   454.52% 0.28%
JANE STREET GROUP, LLC 11/14/2025 161.93 K $333.57 K   100.00% 0.24%
XTX TOPCO LTD 11/14/2025 156.16 K $321.69 K   19.80% 0.23%
AVESTAR CAPITAL, LLC 11/07/2025 140.47 K $289.37 K   0.00% 0.21%
ROYAL BANK OF CANADA 11/14/2025 116.41 K $241.00 K   -39.23% 0.18%
ALPHACORE CAPITAL LLC 11/12/2025 109.93 K $226.45 K   8.22% 0.17%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 101.80 K $209.71 K   -21.51% 0.15%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 95.30 K $196.32 K   128.54% 0.14%
CUBIST SYSTEMATIC STRATEGIES, LLC 11/14/2025 88.90 K $183.14 K   100.00% 0.13%
RHUMBLINE ADVISERS 11/06/2025 87.26 K $179.74 K   2.95% 0.13%
BARCLAYS PLC 11/12/2025 87.24 K $179.71 K   -18.87% 0.13%
HB WEALTH MANAGEMENT, LLC 10/23/2025 71.94 K $148.19 K   100.00% 0.11%
ASSENAGON ASSET MANAGEMENT S.A. 10/07/2025 67.23 K $138.50 K   0.00% 0.10%
MAI CAPITAL MANAGEMENT 11/10/2025 66.29 K $136.56 K   -86.88% 0.10%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 64.11 K $132.06 K   -87.88% 0.10%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 11/14/2025 62.50 K $128.75 K   100.00% 0.09%
WELLS FARGO & COMPANY/MN 11/13/2025 58.52 K $120.55 K   26.83% 0.09%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 55.70 K $114.74 K   0.00% 0.08%
CAPSTONE INVESTMENT ADVISORS, LLC 11/14/2025 51.19 K $105.45 K   0.00% 0.08%
BANK OF AMERICA CORP /DE/ 11/14/2025 49.32 K $101.60 K   -47.19% 0.07%
ALLIANCEBERNSTEIN L.P. 11/14/2025 48.73 K $100.38 K   0.00% 0.07%
AQR CAPITAL MANAGEMENT LLC 11/14/2025 48.28 K $99.46 K   155.17% 0.07%
GLENVIEW TRUST CO 11/07/2025 43.13 K $88.84 K   0.00% 0.06%
WOLVERINE TRADING, LLC 11/14/2025 40.60 K $84.45 K   -13.43% 0.06%
CREATIVE PLANNING 11/14/2025 40.10 K $82.61 K   17.77% 0.06%
ELKHORN PARTNERS LIMITED PARTNERSHIP 11/13/2025 39.00 K $80.34 K   14.71% 0.06%
MILLENNIUM MANAGEMENT LLC 11/14/2025 35.90 K $73.96 K   -96.81% 0.05%
HIGHTOWER ADVISORS, LLC 11/07/2025 34.21 K $70.46 K   0.00% 0.05%
FMR LLC 11/13/2025 32.20 K $66.33 K   -7.70% 0.05%
QUADRATURE CAPITAL LTD 11/13/2025 31.49 K $64.72 K   36.23% 0.05%

Cardiff Oncology, Inc. institutional Ownership - FAQ's

During the previous two years, 145 institutional investors and hedge funds held shares of Cardiff Oncology, Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 3.99 M

VANGUARD GROUP INC: 3.59 M

Laurion Capital Management LP: 2.47 M

PFIZER INC: 2.41 M

BLAIR WILLIAM & CO/IL: 2.21 M

ACORN CAPITAL ADVISORS, LLC: 1.96 M

37.83% of Cardiff Oncology, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 29.16 M shares in the last 24 months. This purchase volume represents approximately $63.27 M in transactions.